Portal de investigação
Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort
Autores da FMUP
Participantes de fora da FMUP
- Brandao, M.
- Goncalves Almeida, J.
- Fonseca, P.
- Faria, R.
- Sousa, O.
- Fonseca, C.
- Portuguese Registry Hypertrophic
Unidades de investigação
Abstract
Abstract no disponible
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Screening of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies (F-CHECK) - NCT05409846
Investigador Principal: Elisabete Lousada Martins Oliveira Bernardes
Estudo Observacional Académico (F-CHECK) . Sanofi . 2022
The Impact of Obesity on Cardiac Function and Morphology in Aortic Stenosis
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (Obesity) . 2020
Suboptimal control of cardiovascular risk factors in myocardial infarction survivors
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico (myocard) . 2020
Modeling Aortic Stenosis progression: impact on follow-up, treatment, and survival
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Epicardial adipose tissue volume is not an independent predictor of atrial fibrillation recurrence after ablation
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Flow-status in severe aortic stenosis for percutaneous valve implantation: Should we follow the flow?
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2022
Cardiovascular Impact of Metabolic Syndrome: From Mechanisms to New Treatment Targets
Investigador Principal: Ricardo Manuel Alves Monteiro Fontes de Carvalho
Estudo Clínico Académico . 2021
Citar a publicação
Brandao,M,Goncalves,J,Fonseca,P,Faria,R,Sousa,O,Fonseca,C,Fontes,R et al. Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:Oxford University Press. 2022 p.p. 1731-1731.
